AIRLINK 145.00 Increased By ▲ 0.50 (0.35%)
BOP 10.17 Increased By ▲ 0.01 (0.1%)
CNERGY 7.20 Increased By ▲ 0.02 (0.28%)
CPHL 81.85 Increased By ▲ 0.45 (0.55%)
FCCL 44.85 Increased By ▲ 0.10 (0.22%)
FFL 15.05 Decreased By ▼ -0.05 (-0.33%)
FLYNG 53.75 Increased By ▲ 0.84 (1.59%)
HUBC 134.01 Decreased By ▼ -0.34 (-0.25%)
HUMNL 11.03 Decreased By ▼ -0.03 (-0.27%)
KEL 5.09 Increased By ▲ 0.04 (0.79%)
KOSM 5.59 Decreased By ▼ -0.01 (-0.18%)
MLCF 79.62 Increased By ▲ 0.12 (0.15%)
OGDC 211.75 Increased By ▲ 0.95 (0.45%)
PACE 5.80 Increased By ▲ 0.10 (1.75%)
PAEL 39.32 Decreased By ▼ -0.28 (-0.71%)
PIAHCLA 22.20 Increased By ▲ 0.50 (2.3%)
PIBTL 8.20 Increased By ▲ 0.05 (0.61%)
POWER 13.69 Increased By ▲ 0.19 (1.41%)
PPL 163.20 Increased By ▲ 1.20 (0.74%)
PRL 32.40 Increased By ▲ 0.20 (0.62%)
PTC 24.10 Increased By ▲ 0.65 (2.77%)
SEARL 84.50 No Change ▼ 0.00 (0%)
SSGC 43.45 Increased By ▲ 0.39 (0.91%)
SYM 14.60 Increased By ▲ 0.15 (1.04%)
TELE 7.58 Increased By ▲ 0.09 (1.2%)
TPLP 9.42 Increased By ▲ 0.03 (0.32%)
TRG 61.99 Increased By ▲ 0.39 (0.63%)
WAVESAPP 9.00 Decreased By ▼ -0.14 (-1.53%)
WTL 1.51 Increased By ▲ 0.02 (1.34%)
YOUW 4.65 Increased By ▲ 0.20 (4.49%)
BR100 12,963 Increased By 40.2 (0.31%)
BR30 37,145 Increased By 171.6 (0.46%)
KSE100 120,407 Increased By 404 (0.34%)
KSE30 36,544 Increased By 102.4 (0.28%)
Pakistan

Interior Minister Ijaz Shah gets first dose of COVID-19 trial vaccine

  • UHS Vice-Chancellor Prof Javed Akram says the minister’s staff members were also administered the trial vaccine
  • China had supplied the medication, developed by Chinese biotech CanSinoBio in partnership with the Beijing Institute of Biotechnology, to Islamabad as part of a trial agreement
Published December 7, 2020

(Karachi) Federal Interior Minister Ijaz Shah has been administered trial vaccine of COVID-19 from China at the University of Health Sciences (UHS) Lahore, local media reported on Monday.

“Interior Minister Ijaz Shah was administered the vaccine, which has been in phase three of clinical trials,” UHS Vice-Chancellor Prof Dr Javed Akram said.

“The minister’s staff members were also administered the trial vaccine,” Prof Akram added.

Earlier, Pakistan began final-phase testing of a Chinese-made vaccine against novel coronavirus, the first ever clinical trial of its kind in the South Asian nation.

China had supplied the COVID-19 medication, developed by Chinese biotech CanSinoBio in partnership with the Beijing Institute of Biotechnology, to Islamabad as part of a trial agreement.

So far, the trial vaccine has seen a positive public response, raising the hope that the effort would meet its target. The specific vaccine has already established its safety and efficacy in the previous trials held in China with no serious adverse effects.

It’s now being tested on a wider population in Russia, Mexico, Chile, Argentina, Saudi Arabia and Pakistan; the country has been allocated 8,000 recruits out of a total of 40,000 and is currently conducting the trial at five centres in Islamabad, Lahore and Karachi.

Comments

Comments are closed.